public speaking anxiety

Bionomics' lead asset fails to reduce public speaking anxiety in phase 2 trials
Fierce Biotech
Mon, 12/19/22 - 11:10 am
Bionomics
BNC210
clinical trials
anxiety
public speaking anxiety